WEBVTT

1
00:00:00.000 --> 00:00:03.036
>> HELLO AND WELCOME TO INSIDE
INDIANA BUSINESS.
I'M GERRY DICK.
FOR MONTHS NOW, ELI LILLY AND

2
00:00:03.036 --> 00:00:09.743
COMPANY HAS BEEN ON THE
FRONTLINES OF THE FIGHT AGAINST
THE COVID-19 PANDEMIC.
AND THIS WEEK, A MAJOR

3
00:00:09.743 --> 00:00:14.381
BREAKTHROUGH, A LILLY-DEVELOPED
ANTIBODY THERAPY GRANTED
EMERGENCY USE AUTHORIZATION FROM
THE FOOD AND DRUG

4
00:00:14.381 --> 00:00:20.053
ADMINISTRATION.
LILLY RESEARCHERS SAY WHEN GIVEN
EARLY, THE TREATMENT MAY HELP
PATIENTS CLEAR THE VIRUS AND

5
00:00:20.053 --> 00:00:29.062
REDUCE COVID-RELATED
HOSPITALIZATIONS.
WITH MORE ON WHAT THE FDA'S
DECISION MEANS FOR PATIENTS AND

6
00:00:29.062 --> 00:00:34.033
FOR THE COMPANY, I'M PLEASED TO
BE JOINED BY LILLY CHIEF
FINANCIAL OFFICER JOSH SMILEY.
JOSH, AS ALWAYS, WELCOME TO THE

7
00:00:34.033 --> 00:00:38.872
PROGRAM.
>> THANK YOU, GERRY.
IT'S GREAT TO SEE YOU.
>> I SAID IT'S A BREAKTHROUGH.

8
00:00:38.872 --> 00:00:46.212
IT'S REALLY BEEN A HERCULEAN
EFFORT ON THE PART OF A LOT OF
PEOPLE THERE AT LILLY.
TYPICALLY IT TAKES YEARS FOR A

9
00:00:46.212 --> 00:00:53.086
DRUG TO COME TO MARKET.
TALK ABOUT WHAT A COMPRESSED
TIME FRAME THIS WAS TO GET THIS
ANTIBODY TREATMENT TO MARKET.

10
00:00:53.086 --> 00:01:03.563
>> YEAH, JUST GOING BACK, WE
STARTED WORKING ON THIS PROGRAM
AT THE END OF FEBRUARY.
WE HAVE A PARTNER IN CANADA WHO

11
00:01:03.563 --> 00:01:10.603
HAS IDENTIFIED SOME SAMPLES OF
PATIENTS, FIRST PATIENTS IN THE
U.S. WHO HAD RECOVERED FROM
COVID, THEY CAME TO US AND WE

12
00:01:10.603 --> 00:01:18.144
DECIDED TO WORK ON A PROGRAM
TOGETHER, SO FROM THE END OF
FEBRUARY TO NOVEMBER, WE TOOK
WHAT TYPICALLY TAKES SOMEWHERE

13
00:01:18.144 --> 00:01:25.385
BETWEEN FIVE AND 10 YEARS AND
GOT IT INTO EIGHT MONTHS TO GET
AN EMERGENCY USE AUTHORIZATION
EARLIER THIS WEEK.

14
00:01:25.385 --> 00:01:33.560
>> WOW, THAT IS TRULY AMAZING.
TALK ABOUT THE ANTIBODY THERAPY.
THIS IS GIVEN TYPICALLY TO
PEOPLE KIND OF EARLY ON IN THE

15
00:01:33.560 --> 00:01:39.732
VIRUS KIND OF PROCESS, IF YOU
WILL, AND SOME DOSING HAS
ALREADY BEEN GIVEN TO PATIENTS
HERE IN INDIANA.

16
00:01:39.732 --> 00:01:47.106
>> THAT'S RIGHT.
YOU KNOW, AS WE STARTED THIS
PROGRAM, WE WEREN'T SURE EXACTLY
WHAT PATIENT POPULATION WOULD

17
00:01:47.106 --> 00:01:52.846
WORK BEST, AND WE'RE STUDYING A
RANGE OF POPULATIONS BUT WHAT
WE'VE RECEIVED THE EMERGENCY USE
AUTHORIZATION FOR ARE FOR

18
00:01:52.846 --> 00:02:00.553
PATIENTS WHO ARE NEWLY
DIAGNOSED, WHO WOULD BE AT HIGH
RISK FOR HOSPITALIZATION, AND
OUR STUDY WOULD INDICATE THAT IF

19
00:02:00.553 --> 00:02:06.793
THOSE PATIENTS, PATIENTS WHO ARE
OLDER, OVER 65 OR OBESE OR HAVE
UNDERLYING CONDITIONS LIKE
DIABETES, IF THEY GET THE DRUG

20
00:02:06.793 --> 00:02:15.134
EARLY IN THE COURSE OF THEIR
DISEASE, OUR STUDY SHOWED OVER A
70% REDUCTION IN THEIR CHANCE OF
BEING HOSPITALIZED.

21
00:02:15.134 --> 00:02:24.511
WE GOT AN APPROVAL MONDAY NIGHT,
SHIPPED DRUG ON TUESDAY, AND THE
FIRST TWO PATIENTS IN THE
COUNTRY RECEIVED THE DRUG AT

22
00:02:24.511 --> 00:02:32.819
CLARK MEMORIAL HOSPITAL IN
JEFFERSONVILLE THIS WEEK.
>> IN TERMS OF THE PRODUCTION,
THAT'S BEING DONE AS I

23
00:02:32.819 --> 00:02:39.392
UNDERSTAND IT AT A PLANT IN NEW
JERSEY.
TALK ABOUT HOW MANY DOSES THE
GOVERNMENT HAS PURCHASED SO FAR,

24
00:02:39.392 --> 00:02:45.098
AND ULTIMATELY HOW MANY MORE YOU
THINK YOU'LL BE PRODUCING AND
SENDING IN THE MONTH AHEAD.
>> THAT'S RIGHT.

25
00:02:45.098 --> 00:02:52.772
AS I MENTIONED, WE'VE HAD TO
MOVE FAST, SO RIGHT NOW WE'RE
WORKING IN ONE FACILITY IN
BRANCHBURG, NEW JERSEY, WHICH

26
00:02:52.772 --> 00:03:03.716
HAS THE CAPACITY TO PRODUCE UP
TO A MILLION DOSES THIS YEAR.
NEXT YEAR WE HAVE FOUR MORE
FACILITIES THAT WILL COME ONLINE

27
00:03:03.716 --> 00:03:14.060
BUT FOR THIS YEAR, THE U.S.¶¶¶ .
GOVERNMENT HAS CONTRACTED TO
PURCHASE 300,000 UNITS OR DOSES,
THE FIRST 88,000 WE SHIPPED ON

28
00:03:14.060 --> 00:03:21.200
TUESDAY, AND AGAIN, THE
OPPORTUNITY WOULD BE TO PROVIDE
UP TO A MILLION DOSES THIS YEAR
TO THE U.S. GOVERNMENT OR OTHER

29
00:03:21.200 --> 00:03:29.175
COUNTRIES AROUND THE WORLD IF WE
HAVE OTHER EMERGENCY USE
AUTHORIZATIONS.
THE GOVERNMENT ALSO THEN HAS AN

30
00:03:29.175 --> 00:03:36.716
OPTION TO PURCHASE ANOTHER
650,000 UNITS OR DOSES BETWEEN
NOW AND THE END OF JUNE, AND
AGAIN, WE'VE GOT LOTS OF

31
00:03:36.716 --> 00:03:40.820
CAPACITY NEXT YEAR TO BE ABLE TO
PROVIDE.
THIS YEAR WE'RE RELATIVELY
LIMITED IN WHAT WE CAN DO.

32
00:03:40.820 --> 00:03:48.528
>> SO CLEARLY PRODUCTION WOULD
CONTINUE, EVEN AFTER A VACCINE
OR VACCINES ARE OUT ON THE
MARKET TOO, PRODUCTION WOULD

33
00:03:48.528 --> 00:03:55.101
CONTINUE.
>> YEAH, OF COURSE WE LIKE
EVERYONE ELSE ARE VERY ANXIOUS
AND WE'RE EXCITED BY THE PFIZER

34
00:03:55.101 --> 00:04:00.006
DATA ON THE VACCINE AND THE
OTHER DATA THAT WILL COME, BUT I
THINK CERTAINLY BETWEEN NOW AND
SUMMER OF NEXT YEAR, THERE'S

35
00:04:00.006 --> 00:04:07.347
GOING TO BE A NEED FOR ANTIBODY
TREATMENT, AND THEN WE'VE GOT A
LONG ROLLOUT BEFORE THE WORLD IS
ABLE TO FULLY ACCESS THE

36
00:04:07.347 --> 00:04:15.788
BENEFITS OF VACCINE, SO WE SEE
THIS CERTAINLY AS AN IMPORTANT
BRIDGE FOR THE NEXT PROBABLY 12
TO 18 MONTHS.

37
00:04:15.788 --> 00:04:27.867
>> JOSH, VERY EARLY ON IN THE
DISEASE, THE VIRUS, THE LILLY
CEO WAS OUT FRONT SAYING LILLY
REALLY WANTED TO ENGAGE AND BE

38
00:04:27.867 --> 00:04:34.907
ON THE FRONT LINES IN THE FIGHT
AGAINST THE PANDEMIC.
THERE WAS THE DRIVE-THRU TESTING
AT THE LILLY HEADQUARTERS, NOW

39
00:04:34.907 --> 00:04:39.912
OBVIOUSLY THE ANTIBODY THERAPY
IS OUT.
THIS HAS BEEN A VERY INTENTIONAL
EFFORT, IT SEEMS TO ME, TO

40
00:04:39.912 --> 00:04:48.888
REALLY TAKE A LEADERSHIP ROLE IN
THE FIGHT AGAINST COVID-19.
>> YEAH, IT'S WHAT WE DO.
OUR MISSION AS A COMPANY IS TO

41
00:04:48.888 --> 00:04:56.129
MAKE LIVES BETTER FOR PEOPLE.
COVID, OF COURSE, IS A VERY
UNIQUE PANDEMIC, BUT WE'VE
REALLY TAKEN ALL OF THE

42
00:04:56.129 --> 00:05:03.236
RESOURCES WE CAN AND PUT THEM
AGAINST EVERY WAY WE CAN HELP.
OF COURSE THE ANTIBODY AS YOU
MENTIONED, GERRY, TESTING, WE

43
00:05:03.236 --> 00:05:09.175
CONTINUE TO LOOK AT OTHER
THERAPEUTICS THAT CAN HELP.
WE ACTUALLY HAVE ANOTHER
EMERGENCY USE AUTHORIZATION FOR

44
00:05:09.175 --> 00:05:19.686
A DRUG THAT HELPS WHEN PATIENTS
ARE ALREADY HOSPITALIZED.
SO WE REALLY HAVE PUT THE FULL
WEIGHT BEHIND US.

45
00:05:19.686 --> 00:05:26.526
>> MAJOR BREAK, ANTIBODY
TREATMENT NOW DOSING BEING GIVEN
TO PATIENTS AND WITH MANY MORE
IN THE FUTURE.

46
00:05:26.526 --> 00:05:32.331
JOSH SMILEY, LILLY CFO, JOSH,
THANKS FOR TAKING THE TIME, WE
LOOK FORWARDS TO VISITING AGAIN